|
Name |
Drechmerin F
|
Molecular Formula | C32H45NO7 | |
IUPAC Name* |
(1S,2R,5S,7S,8R,9R,11S,12S,15S)-19-[(2R)-2,3-dihydroxy-3-methylbutyl]-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6,10-dioxa-24-azaheptacyclo[13.10.0.02,12.05,11.09,11.017,25.018,23]pentacosa-17(25),18,20,22-tetraene-8,12-diol
|
|
SMILES |
C[C@]12CC[C@H]3[C@@]4([C@@]1(CC[C@@H]5[C@@]2(C6=C(C5)C7=C(C=CC=C7N6)C[C@H](C(C)(C)O)O)C)O)[C@H](O4)[C@@H]([C@H](O3)C(C)(C)O)O
|
|
InChI |
InChI=1S/C32H45NO7/c1-27(2,36)20(34)14-16-8-7-9-19-22(16)18-15-17-10-13-31(38)29(5,30(17,6)24(18)33-19)12-11-21-32(31)26(40-32)23(35)25(39-21)28(3,4)37/h7-9,17,20-21,23,25-26,33-38H,10-15H2,1-6H3/t17-,20+,21-,23+,25-,26+,29+,30+,31-,32-/m0/s1
|
|
InChIKey |
LYESATKXHSZHJC-DGWXCJBRSA-N
|
|
Synonyms |
Drechmerin F
|
|
CAS | NA | |
PubChem CID | 139590918 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 555.7 | ALogp: | 2.6 |
HBD: | 6 | HBA: | 7 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 139.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 40 | QED Weighted: | 0.318 |
Caco-2 Permeability: | -5.651 | MDCK Permeability: | 0.00000525 |
Pgp-inhibitor: | 0.57 | Pgp-substrate: | 0.995 |
Human Intestinal Absorption (HIA): | 0.247 | 20% Bioavailability (F20%): | 0.125 |
30% Bioavailability (F30%): | 0.106 |
Blood-Brain-Barrier Penetration (BBB): | 0.447 | Plasma Protein Binding (PPB): | 68.55% |
Volume Distribution (VD): | 0.714 | Fu: | 16.36% |
CYP1A2-inhibitor: | 0.03 | CYP1A2-substrate: | 0.804 |
CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.555 |
CYP2C9-inhibitor: | 0.045 | CYP2C9-substrate: | 0.082 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.193 |
CYP3A4-inhibitor: | 0.219 | CYP3A4-substrate: | 0.369 |
Clearance (CL): | 5.635 | Half-life (T1/2): | 0.275 |
hERG Blockers: | 0.515 | Human Hepatotoxicity (H-HT): | 0.709 |
Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.054 |
Rat Oral Acute Toxicity: | 0.986 | Maximum Recommended Daily Dose: | 0.969 |
Skin Sensitization: | 0.368 | Carcinogencity: | 0.932 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.989 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001966 | 0.703 | D0H2JP | 0.253 | ||||
ENC003930 | 0.560 | D06AWE | 0.253 | ||||
ENC003931 | 0.560 | D02IQY | 0.239 | ||||
ENC003834 | 0.485 | D06YFA | 0.226 | ||||
ENC002013 | 0.479 | D02ZGI | 0.224 | ||||
ENC003787 | 0.473 | D05SHK | 0.216 | ||||
ENC005557 | 0.469 | D0W2EK | 0.216 | ||||
ENC003329 | 0.427 | D01KQA | 0.212 | ||||
ENC000836 | 0.424 | D02JNM | 0.209 | ||||
ENC004710 | 0.414 | D0O5WP | 0.204 |